Moneycontrol » News » CNBC-TV18 Comments

Maytas ineligible to bid for Hyderabad metro rail, again

Published on Sat, Jul 25, 2009 at 16:34 |  Source : CNBC-TV18

Updated at Sat, Jul 25, 2009 at 19:37  

8475 Investors following Maytas Infra. Share this News with them.
0
0
Share on Tumblr

Maytas Infra , which is hoping to rebid for the Rs 12,000 crore Hyderabad metro rail project once again, might find itself ineligible to do so. CNBC-TV18's Vishwanath Pilla reports.

The Andhra Pradesh government, which terminated the Rs 12,000 crore Hyderabad metro rail project awarded to Maytas Infra in consortium a couple of weeks back, is ensuring that the company and its consortium partners will become ineligible to rebid for the project. The request for qualification document released by the Hyderabad metro rail authorities says, "Any consortium member or associate expelled from any project or contract by any public entity will become ineligible for the project."

The document also stated that the Andhra Pradesh government got in-principle approval from the centre to get a viability gap funding of Rs 2,363 crore, which is 20% of the total cost of the project.

Apart from this, there is also a provision of both the government of Andhra Pradesh and the centre to fund the project to the extent of 40%. Also, the successful bidder will get 18.5 lakh sq ft of real estate development in 34 stations across the metro rail project.

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com